Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Metabolic Brain Disease|March 5, 2021
Protective mechanism of Syringic acid in an experimental model of Parkinson's diseaseÖzge Güzelad, Ayşe Özkan, Hande Parlak, et al.
Neurochemistry International|September 30, 2014
Mechanism of the beneficial effect of melatonin in experimental Parkinson's diseaseFatos Belgin Yildirim, Ozlem Ozsoy, Gamze Tanriover, et al.
Neuropharmacology|January 29, 2022
Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson's disease via targeting TLR-2 mediated neuroinflammationDilara Nemutlu Samur, Güven Akçay, Sendegül Yıldırım, et al.
Neuroscience|June 8, 2024
Protective Effects of Adropin in Experimental Subarachnoid HemorrhageAyşenur Sümer Coşkun, Mehmet Bülbül, Tuğçe Çeker, et al.
Transplantation Proceedings|August 20, 2021
Serum Levels of S100β, Neuron-Specific Enolase, Glial Fibrillary Acidic Protein in Kidney Transplant Recipients and Donors: A Prospective Cohort StudyBora Dinc, Vural Taner Yılmaz, Mutay Aslan, et al.
Anesthesiology|December 27, 2003
Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endotheliumJohn D Lang, Mario Figueroa, Phillip Chumley, et al.
The Journal of Biological Chemistry|October 29, 2002
Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerizationMutay Aslan, Thomas M Ryan, Tim M Townes, et al.
The Journal of Surgical Research|April 9, 2025
Assessment of Amniotic Fluid as a Preservation Solution in Pig Livers Undergoing Machine PerfusionOzgur Dandin, Sendegul Yildirim, Deniz Karacayli, et al.
Lipids|March 3, 2020
Plasma Ceramides and Sphingomyelins of Pediatric Patients Increase in Primary Ciliary Dyskinesia but Decrease in Cystic FibrosisDilara Bal Topçu, Gokcen Tugcu, Filiz Ozcan, et al.
Redox Biology|June 4, 2017
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)Javier Egea, Isabel Fabregat, Yves M Frapart, et al.
Pageof 12